26,2 MSEK from Cancerfonden to researchers at Labmed
Congratulations to the 9 researchers at Labmed who received funds from Cancerfonden 2024-2026.
Peter Bergman, Professor
Title: "Kan ett nytt läkemedel minska tarmskada vid cytostatika-behandling genom aktivering av den naturliga immuniteten i tarmens slemhinna?"
Project grant: 2024-2026, total amount: 2 400 000 SEK.
Mikael Björnstedt, Professor
Title: "Redox-active selenium compounds in the treatment of resistant cancer - translational and clinical studies."
Project grant: 2024-2026, total amount: 3 750 000 SEK.
Daniel Hagey, Research specialist
Title: "Multi-cancer early detection via RNA-sequencing of extracellular vesicles from blood drops."
Project grant: 2024-2026, total amount: 2 400 000 SEK.
Helen Kaipe, Researcher
Title: "Exploring tumor-infiltrating T cells and cancer-associated fibroblasts in the pancreatic tumor microenvironment."
Project grant: 2024-2026, total amount: 2 400 000 SEK.
Anders Mutvei, Principal Researcher
Title: "Lysosome abundance and organization in cancer."
Project grant: 2024-2026, total amount: 3 000 000 SEK.
Anna Pasetto, Research specialist
Title: "Design av neoantigen-baserat vacciner mot levercancer."
Project grant: 2024-2026, total amount: 2 400 000 SEK.
Dhifaf Sarhan, Docent
Title: "Study adaptive NK cells in cancer"
Project grant: 2024-2026, total amount: 3 000 000 SEK.
Matti Sällberg, Professor
Title: "Genetic vaccines and immune-based therapies to prevent cancer caused by chronic hepatitis B, C and D virus infections: Therapy development and models."
Project grant: 2024-2026, total amount: 4 500 000 SEK.
Oscar Wiklander, Researcher
Title: "Exosome-based liquid biopsy and targeted therapy.
Project grant: 2024-2026, total amount: 2 400 000 SEK.